Welcome to our dedicated page for So-Young Intl news (Ticker: SY), a resource for investors and traders seeking the latest updates and insights on So-Young Intl stock.
So-Young International Inc. (Nasdaq: SY) is described as the leading aesthetic treatment platform in China, connecting consumers with online services and offline treatments. The news flow around SY focuses heavily on quarterly financial and operational updates, corporate actions related to its listing, and developments in its branded aesthetic center network and product activities.
Investors following SY news will see regular unaudited financial results releases furnished on Form 6-K, covering revenue composition across aesthetic treatment services, information and reservation services, sales of medical products and maintenance services, and other services. These announcements also provide detail on cost of revenues, operating expenses, non-GAAP metrics and cash positions, giving readers insight into how So-Young’s business mix is evolving over time.
Operational highlights in So-Young’s news include the number of fully operational branded aesthetic centers in major Chinese cities, verified treatment visits, verified aesthetic treatments performed and active users visiting the centers. The company also discloses information on the number of institutions served with supply chain solutions for injectables and shipment volumes for injectable products such as Elasty, illustrating activity in its upstream product and supply chain segment.
Corporate and capital market updates are another recurring theme in SY news. So-Young has issued press releases on plans and timing for ADS ratio changes, as well as notifications about regaining compliance with Nasdaq’s minimum bid price requirement. The company also announces the filing of its annual report on Form 20-F and provides schedules and dial-in details for earnings conference calls.
For readers and investors, the SY news page offers a centralized view of So-Young’s financial performance, operational metrics, listing-related developments and strategic updates. Monitoring these releases can help track how the company’s aesthetic treatment platform, branded centers and medical aesthetic product activities are progressing over time.
So-Young International Inc. (Nasdaq: SY) has announced its compliance with Nasdaq's minimum bid price requirement of US$1.00 per share, effective January 4, 2023. Previously notified of non-compliance on July 15, 2022, the Company regained compliance after the closing bid price remained above US$1.00 for 11 consecutive business days from December 16, 2022, to January 3, 2023. Nasdaq has deemed this matter closed, which is a positive development for the Company.
So-Young International Inc. (Nasdaq: SY) has increased its Share Repurchase Program from US$15 million to US$25 million. This decision reflects the Company's confidence in its long-term prospects within the expanding medical aesthetics market. The program is effective for 12 months starting from November 18, 2022, allowing repurchases in various market conditions. So-Young aims to fund these repurchases from its cash balance, highlighting its commitment to enhancing shareholder value.
So-Young International Inc. (SY) reported its Q3 2022 financial results, revealing total revenues of RMB323.3 million (US$45.5 million), a 25.1% decline year-over-year. The company recorded a net income of RMB2.3 million (US$0.3 million), down from RMB6.8 million in Q3 2021. The decrease in revenues was attributed to challenges posed by COVID-19. Despite a 28.1% year-over-year increase in paying medical service providers to 6,199, active monthly users dropped to 3.9 million from 8 million a year earlier. The board authorized a US$15 million share repurchase program to enhance shareholder value.
So-Young International Inc. (NASDAQ: SY) will release its financial results for Q3 2022 on November 18, 2022, prior to U.S. market opening. Following this, an earnings conference call is scheduled for 7:00 AM ET the same day, with dial-in options for international, U.S., and China callers. The call will be accessible via a live and archived webcast on the company's investor relations website. So-Young continues to serve as a leading social community in China for the medical aesthetics sector, fostering a trustworthy platform for users.
So-Young International Inc. (Nasdaq: SY) announced the immediate withdrawal of its non-binding going private proposal by Chairman and CEO Mr. Xing Jin. This decision follows a review of current market conditions, leading the board to dissolve the special committee overseeing the proposal. So-Young remains positioned as a leading social community in China's medical aesthetics industry, emphasizing its trusted platform and extensive service provider network.
So-Young International Inc. (SY) reported its second quarter financial results for 2022, showing total revenues of RMB309.1 million (US$46.1 million), down 31.6% year-over-year. The company posted a net loss of RMB32.3 million (US$4.8 million), a decline from a net income of RMB57.6 million in Q2 2021. Average mobile monthly active users fell to 3.5 million from 10 million a year ago. Despite challenges, the number of paying medical service providers grew by 17.1% to 5,735. For Q3 2022, So-Young anticipates revenues between RMB310 million and RMB330 million, indicating a continued decline from the previous year.
So-Young International Inc. (NASDAQ: SY) will report its financial results for the second quarter ended June 30, 2022, before U.S. markets open on August 16, 2022. An earnings conference call will follow on the same day at 7:30 AM U.S. Eastern Time. Due to COVID-19, participants must preregister online to receive dial-in details. So-Young is a leading platform in China's medical aesthetics industry, providing trusted information and community engagement for consumers and service providers.
So-Young International Inc. (Nasdaq: SY) announced it received a notification from Nasdaq regarding non-compliance with minimum bid price requirements, as its ADSs closed below $1.00 for 30 consecutive days. The company has until January 11, 2023, to regain compliance. If the ADS price reaches $1.00 for at least ten consecutive business days, Nasdaq will confirm compliance. The notification does not affect business operations, and So-Young plans to take measures to regain compliance within the grace period.
So-Young International (SY) reported unaudited financial results for Q1 2022, with total revenues of RMB300.3 million, down 16.5% year-over-year. The net loss widened to RMB66.8 million from RMB45.0 million in Q1 2021. Average monthly active users decreased significantly to 4.4 million from 8.4 million. Despite challenges from COVID-19, the company saw a 11.7% increase in paying medical service providers, totaling 5,254. The decline in revenue stemmed largely from reduced average revenue per provider, prompting a cautious outlook with no revenue guidance for Q2 2022 amid ongoing uncertainties.
So-Young International Inc. (NASDAQ: SY) will report its financial results for the first quarter ending March 31, 2022, on May 23, 2022, before U.S. markets open. As the largest social community in China focused on medical aesthetics, So-Young connects consumers and service providers, driving engagement and trust within the sector. The earnings release will be available on the Company's investor relations webpage, highlighting its position to expand in both medical aesthetics and the broader healthcare service market.
FAQ
What is the current stock price of So-Young Intl (SY)?
What is the market cap of So-Young Intl (SY)?
